Reply to commentary on ‘effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular kidney-metabolic comorbidity’

By afschroeder • March 3, 2026

Siddiqi TJ, Khan MS, Fonarow GC, Butler J, Greene SJ. Reply to commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular kidney-metabolic comorbidity'. Eur J Heart Fail. 2026 Jan 8:xuaf004. doi: 10.1093/ejhf/xuaf004. Epub ahead of print. PMID: 41771103.

Tags: Cardiology/Epi, Chronic kidney disease, diabetes, GLP-1 receptor agonist, heart failure, Obesity, Publications

Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease Summit

Zaidi AN, Sachdeva R, Kovacs R, Franklin WJ, Gurvitz M, Ermis P, Awerbach JD, Weissman G, Bradley E, Cox D, Daniels CJ, Gregg D 4th,[...]

Longitudinal Data from the KETO-CTA Study: Plaque Predicts Plaque, ApoB Does Not: JACC Adv. 2025;4(7):101686

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Longitudinal Data from the KETO-CTA Study: Plaque Predicts Plaque,[...]

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]